cognitive cybersecurity intelligence

News and Analysis

Search

FDA, CISA advise on genomic device software vulnerabilities

While Illumina has yet to receive any reports indicating this vulnerability has been exploited, according to a letter to healthcare providers from the U.S. Food and Drug Administration, bad actors could take control of the devices, alter the software and patient test results or compromise a…

Source: www.healthcareitnews.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts